
Biopharma global sales forecast by chain type 2016-2022
In 2016, the global cold chain biopharmaceutical sales stood at 272 billion U.S. dollars, and is predicted to grow to over 1.4 trillion until 2022. Over the entire given period, the global cold chain market is forecasted to grow by 53 percent, versus 26 percent for the non-cold chain market.